Outcomes in Real-life After Initation Of treatmeNt With Trixeo (Budesonide / Glycopyrronium / Formoterol), a Non-interventional, Multi-centre, Prospective Cohort Study in Italian Routine Care Setting
Latest Information Update: 03 Jul 2025
At a glance
- Drugs Budesonide/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms CHOROS ORION
- Sponsors AstraZeneca
Most Recent Events
- 26 Jun 2025 Status changed from active, no longer recruiting to completed.
- 19 Jun 2024 Planned End Date changed from 30 Jun 2025 to 28 Jul 2025.
- 19 Jun 2024 Planned primary completion date changed from 30 Jun 2025 to 28 Jul 2025.